Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yuwa,Ando

第一单位： Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

作者： Yuwa,Ando ^[1] ; Tomokazu,Kawaoka ^[1] ; Masanari,Kosaka ^[1] ; Yuki,Shirane ^[1] ; Yusuke,Johira ^[1] ; Ryoichi,Miura ^[1] ; Serami,Murakami ^[1] ; Shigeki,Yano ^[1] ; Kei,Amioka ^[1] ; Kensuke,Naruto ^[1] ; Yumi,Kosaka ^[1] ; Shinsuke,Uchikawa ^[1] ; Kenichiro,Kodama ^[1] ; Hatsue,Fujino ^[1] ; Takashi,Nakahara ^[1] ; Atushi,Ono ^[1] ; Eisuke,Murakami ^[1] ; Masami,Yamauchi ^[1] ; Wataru,Okamoto ^[2] ; Shoichi,Takahashi ^[1] ; Michio,Imamura ^[2] ; Hiroshi,Aikata ^[1]

作者单位： Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. ^[1] Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan. ^[2]

关键词 Adverse events Atezolizumab plus bevacizumab Hepatocellular carcinoma Proteinuria Vascular endothelial growth factor

DOI 10.1159/000528145

PMID 37601981

发布时间 2023-08-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Liver cancer

2023年12卷3期

251-261页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Liver cancer

相似文献

Liver cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Liver cancer

相似文献

Liver cancer

相关期刊

检索历史清除